Skip to Content
Get key facts and figures about chronic dry eye

Lidocaine ophthalmic Pregnancy and Breastfeeding Warnings

Lidocaine ophthalmic is also known as: Akten

Lidocaine ophthalmic Pregnancy Warnings

This drug should be used during pregnancy only if clearly needed.

US FDA pregnancy category: B

Animal studies failed to reveal evidence of fetal harm when this drug was administered subcutaneously at doses more than 800-fold greater than the human dose, based on body weight. There are no controlled data in human pregnancy.

US FDA pregnancy category B: Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.

See references

Lidocaine ophthalmic Breastfeeding Warnings

Caution is recommended.

Excreted into human milk: Unknown
Excreted into animal milk: Data not available

Comments:
-This drug is secreted in human milk following systemic use; while no systemic exposure is expected with the ophthalmic formulation, caution is advised.
-The effects in the nursing infant are unknown.

See references

References for pregnancy information

  1. "Product Information. Akten (lidocaine ophthalmic)." Akorn Inc, Buffalo Grove, IL.

References for breastfeeding information

  1. "Product Information. Akten (lidocaine ophthalmic)." Akorn Inc, Buffalo Grove, IL.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide